
The rising incidence of alcohol-associated hepatocellular carcinoma (HCC) correlates with increasing alcohol consumption. This study systematically assessed its prevalence, clinical characteristics, surveillance rates, treatment allocation, and outcomes. A meta-analysis of 55 studies (86,345 patients) revealed that 30.4% of HCC cases are alcohol-associated, predominantly in Europe. Patients with alcohol-associated HCC, often male, had lower surveillance rates (20.8%) and were less likely to receive curative therapy (24.5%) compared to other causes. They presented at more advanced stages and had higher mortality rates. These findings highlight the need for improved HCC surveillance and strategies to mitigate heavy alcohol consumption in high-risk groups.
Like
Save
Share